Specifically, we demonstrate that HSP90β expression is significantly higher in ACC in comparison to benign adrenocortical adenomas independently of their endocrine activity, while HSP90α/β is more evenly distributed among these tumor entities. This evidence concerns the gene HSP90AA1 and adrenal cortex carcinoma.